Examining the Role of Negative Emotional States on Sedative Drug Use in Individuals With Post-Traumatic Stress Disorder
NCT00244335 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 39
Last updated 2017-01-10
Summary
Post-traumatic stress disorder (PTSD) is a serious illness, in which individuals often experience anxiety and stress. Some individuals with PTSD use drugs to alleviate emotional distress. This study will examine the role that negative emotional states play in sedative drug use among individuals with PTSD.
Conditions
- Stress Disorders, Post-Traumatic
Sponsors & Collaborators
-
The University of Texas Health Science Center at San Antonio
collaborator OTHER -
National Institute on Drug Abuse (NIDA)
lead NIH
Principal Investigators
-
John Casada, MD · University of Texas Health Science Center San Antonio
Eligibility
- Min Age
- 18 Years
- Max Age
- 60 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2000-10-31
- Primary Completion
- 2006-02-28
- Completion
- 2008-07-31
Countries
- United States
Study Locations
More Related Trials
-
Non-sedation Versus Sedation With a Daily Wake-up Trial in Critically Ill Patients Receiving Mechanical Ventilation - Effects on PTSD
NCT02040649 ·Status: COMPLETED ·Phase: NA
-
Exploring Nitrous Oxide Effects for Post Traumatic Stress Disorder (PTSD)
NCT03375294 ·Status: COMPLETED ·Phase: PHASE2
-
Utility of Amantadine Hydrochloride in the Treatment of Post-traumatic Irritability
NCT00627250 ·Status: COMPLETED ·Phase: NA
-
A Policy Relevant US Trauma Care System Pragmatic Trial for PTSD and Comorbidity Pilot
NCT02335125 ·Status: COMPLETED ·Phase: NA
-
Topiramate in the Treatment of Post Traumatic Stress Disorder (PTSD)
NCT00203463 ·Status: COMPLETED ·Phase: PHASE4
-
Towards a Post-exposition Pharmacological Prophylaxis for Post-traumatic Stress Disorder
NCT04508166 ·Status: COMPLETED ·Phase: NA
-
A Study to Assess the Use of Methylone in the Treatment of PTSD
NCT05741710 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Oxytocin and Affect Processing in Posttraumatic Stress Disorder
NCT02546570 ·Status: COMPLETED ·Phase: PHASE2
-
The Effect of Oxytocin on Fear Memory Consolidation Novel Intervention to Prevent Posttraumatic Stress Disorder (PTSD)
NCT01466127 ·Status: COMPLETED ·Phase: NA
-
The Effects of the Safe and Sound Protocol on PTSD Symptoms and Anxiety
NCT04999852 ·Status: COMPLETED ·Phase: NA
-
Characteristics of Post-Traumatic Stress Disorder (PTSD) and Non-PTSD Subjects
NCT00229359 ·Status: COMPLETED
-
Ketamine Infusion for Comorbid PTSD and Chronic Pain
NCT04322968 ·Status: COMPLETED ·Phase: PHASE3
-
Narrative Exposure Based Intervention For Post-Traumatic Stress Disorder
NCT03229525 ·Status: UNKNOWN ·Phase: NA
-
Web-based CBT for Recent Veterans Experiencing Problems With Trauma Symptoms or Alcohol/Drug Use
NCT01710943 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Software as a Medical Device for the Treatment of Patients With PTSD
NCT06589505 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
Compassion Meditation for PTSD
NCT02372396 ·Status: COMPLETED ·Phase: NA
-
An Open Label Pilot Study of IV Brexanolone for the Treatment of Post-Traumatic Stress Disorder
NCT05254405 ·Status: TERMINATED ·Phase: PHASE4
-
Testing a Causal Model of Cognitive Control Deficits in Posttraumatic Stress Disorder (PTSD)
NCT06016673 ·Status: COMPLETED ·Phase: NA
-
Post Traumatic Stress Disorder (PTSD) Hyperarousal Symptoms Treated With Physiological Stress Management
NCT00855816 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Prevention of Posttraumatic Stress Disorder (PTSD) With Diazepam
NCT01221883 ·Status: UNKNOWN ·Phase: PHASE4
-
Use of CBD Oil in the Treatment of Posttraumatic Stress Disorder
NCT04197102 ·Status: SUSPENDED ·Phase: PHASE2
-
Managing Sleep Symptoms and Modifying Mechanisms of Traumatic Stress
NCT01743339 ·Status: COMPLETED ·Phase: NA
-
Emotion Regulation Selection Flexibility Training for PTSD Patients
NCT06943560 ·Status: RECRUITING ·Phase: NA
-
Cortisol Suppression and Startle Responses in Posttraumatic Stress Disorder (PTSD)
NCT01477762 ·Status: COMPLETED ·Phase: NA
-
Short Course Glucocorticoid Treatment for PTSD
NCT00204737 ·Status: COMPLETED ·Phase: PHASE4